{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T06:52:05Z","timestamp":1786258325230,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1245\/s10434-020-09341-5","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T19:02:36Z","timestamp":1605466956000},"page":"3490-3500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma"],"prefix":"10.1245","volume":"28","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yange","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"issue":"33","key":"9341_CR1","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2012.47.3728","volume":"31","author":"AC Geller","year":"2013","unstructured":"Geller AC, Clapp RW, Sober AJ, et al. Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. Journal of clinical oncology. 2013;31(33):4172\u20134178.","journal-title":"Journal of clinical oncology."},{"issue":"9","key":"9341_CR2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/djaa012","volume":"112","author":"EZ Keung","year":"2020","unstructured":"Keung EZ, Gershenwald JE. Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma. Journal of the National Cancer Institute. 2020;112(9):875\u2013885.","journal-title":"Journal of the National Cancer Institute."},{"issue":"3","key":"9341_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.soc.2020.02.010","volume":"29","author":"CH O\u2019Neill","year":"2020","unstructured":"O\u2019Neill CH, McMasters KM, Egger ME. Role of Surgery in Stage IV Melanoma. Surgical oncology clinics of North America. 2020;29(3):485\u2013495.","journal-title":"Surgical oncology clinics of North America."},{"key":"9341_CR4","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer journal for clinicians. 2018;68(1):7\u201330.","DOI":"10.3322\/caac.21442"},{"issue":"5","key":"9341_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/CMR.0000000000000382","volume":"27","author":"LJ Gardner","year":"2017","unstructured":"Gardner LJ, Ward M, Andtbacka RHI, et al. Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Melanoma research. 2017;27(5):477\u2013484.","journal-title":"Melanoma research."},{"issue":"6","key":"9341_CR6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ejcts\/ezz211","volume":"56","author":"J Viehof","year":"2019","unstructured":"Viehof J, Livingstone E, Loscha E, et al. Prognostic factors for pulmonary metastasectomy in malignant melanoma: size matters. European journal of cardio-thoracic surgery. 2019;56(6):1104\u20131109.","journal-title":"European journal of cardio-thoracic surgery."},{"issue":"3","key":"9341_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cjp2.161","volume":"6","author":"R Barnhill","year":"2020","unstructured":"Barnhill R, van Dam PJ, Vermeulen P, et al. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value. The journal of pathology Clinical research. 2020;6(3):195\u2013206.","journal-title":"The journal of pathology Clinical research."},{"key":"9341_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molimm.2020.01.008","volume":"119","author":"H Wu","year":"2020","unstructured":"Wu H, Xia L, Jia D, et al. PD-L1(+) regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis. Molecular immunology. 2020;119:83\u201391.","journal-title":"Molecular immunology."},{"issue":"3","key":"9341_CR9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1159\/000504019","volume":"12","author":"S Yoshida","year":"2019","unstructured":"Yoshida S, Fujimura T, Kambayashi Y, Amagai R, Hashimoto A, Aiba S. Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy. Case reports in oncology. 2019;12(3):829\u2013833.","journal-title":"Case reports in oncology."},{"issue":"11","key":"9341_CR10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(06)70938-X","volume":"7","author":"DW Ollila","year":"2006","unstructured":"Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. The Lancet Oncology. 2006;7(11):919\u2013924.","journal-title":"The Lancet Oncology."},{"issue":"13","key":"9341_CR11","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","volume":"24","author":"MB Faries","year":"2017","unstructured":"Faries MB, Mozzillo N, Kashani-Sabet M, et al. Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases. Annals of surgical oncology. 2017;24(13):3991\u20134000.","journal-title":"Annals of surgical oncology."},{"issue":"3","key":"9341_CR12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejso.2016.11.001","volume":"43","author":"K Lasithiotakis","year":"2017","unstructured":"Lasithiotakis K, Zoras O. Metastasectomy in cutaneous melanoma. European journal of surgical oncology. 2017;43(3):572\u2013580.","journal-title":"European journal of surgical oncology."},{"issue":"6","key":"9341_CR13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/annonc\/mdw134","volume":"27","author":"MH Geukes Foppen","year":"2016","unstructured":"Geukes Foppen MH, Brandsma D, Blank CU, van Thienen JV, Haanen JB, Boogerd W. Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma. Annals of oncology. 2016;27(6):1138\u20131142.","journal-title":"Annals of oncology."},{"key":"9341_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2016.01.011","volume":"60","author":"M Harries","year":"2016","unstructured":"Harries M, Malvehy J, Lebbe C, et al. Treatment patterns of advanced malignant melanoma (stage III-IV): a review of current standards in Europe. European journal of cancer. 2016;60:179\u2013189.","journal-title":"European journal of cancer."},{"issue":"4","key":"9341_CR15","doi-asserted-by":"crossref","first-page":"934.e916","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017;171(4):934\u2013949.e916.","journal-title":"Cell."},{"issue":"12","key":"9341_CR16","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1016\/S1470-2045(18)30596-5","volume":"19","author":"JJ Grob","year":"2018","unstructured":"Grob JJ, Garbe C, Ascierto P, Larkin J, Dummer R, Schadendorf D. Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma? The Lancet. Oncology. 2018;19(12):e720\u2013e725.","journal-title":"The Lancet. Oncology."},{"issue":"7","key":"9341_CR17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","volume":"17","author":"SB Goldberg","year":"2016","unstructured":"Goldberg SB, Gettinger SN, Mahajan A, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. The Lancet Oncology. 2016;17(7):976\u2013983.","journal-title":"The Lancet Oncology."},{"issue":"8","key":"9341_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nature reviews Clinical oncology. 2017;14(8):463\u2013482.","journal-title":"Nature reviews Clinical oncology."},{"issue":"1","key":"9341_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jid.2018.07.009","volume":"139","author":"A Nosrati","year":"2019","unstructured":"Nosrati A, Yu WY, McGuire J, et al. Outcomes and Risk Factors in Patients with\u00a0Multiple Primary Melanomas. The Journal of investigative dermatology. 2019;139(1):195\u2013201.","journal-title":"The Journal of investigative dermatology."},{"issue":"16","key":"9341_CR20","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.3346\/jkms.2019.34.e126","volume":"34","author":"JE Kim","year":"2019","unstructured":"Kim JE, Chung BY, Sim CY, Park AY, Lee JS, Whang KU, et al.. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea. Journal of Korean medical science. 2019;34(16):e126.","journal-title":"Journal of Korean medical science."},{"issue":"63","key":"9341_CR21","doi-asserted-by":"crossref","first-page":"32173","DOI":"10.18632\/oncotarget.25864","volume":"9","author":"AG Richetta","year":"2018","unstructured":"Richetta AG, Valentini V, Marraffa F, et al. Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile. Oncotarget. 2018;9(63):32173\u201332181.","journal-title":"Oncotarget."},{"issue":"18","key":"9341_CR22","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1002\/cam4.2644","volume":"8","author":"H Liu","year":"2019","unstructured":"Liu H, Xu YB, Guo CC, Li MX, Ji JL, Dong RR, et al. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis. Cancer medicine. 2019;8(18):7577\u20137585.","journal-title":"Cancer medicine."},{"issue":"3","key":"9341_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cmpb.2010.01.001","volume":"99","author":"LC de Wreede","year":"2010","unstructured":"de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Computer methods and programs in biomedicine. 2010;99(3):261\u2013274.","journal-title":"Computer methods and programs in biomedicine."},{"key":"9341_CR24","doi-asserted-by":"crossref","first-page":"g14","DOI":"10.1136\/bmj.g14","volume":"348","author":"VW Jaddoe","year":"2014","unstructured":"Jaddoe VW, de Jonge LL, Hofman A, Franco OH, Steegers EA, Gaillard R. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;348:g14.","journal-title":"BMJ."},{"issue":"25","key":"9341_CR25","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","volume":"343","author":"WN Kernan","year":"2000","unstructured":"Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. The New England journal of medicine. 2000;343(25):1826\u20131832.","journal-title":"The New England journal of medicine."},{"issue":"3","key":"9341_CR26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","volume":"364","author":"GW Stone","year":"2011","unstructured":"Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. The New England journal of medicine. 2011;364(3):226\u2013235.","journal-title":"The New England journal of medicine."},{"issue":"2","key":"9341_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337\u2013344.","journal-title":"Biometrics."},{"issue":"6","key":"9341_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Medical decision making. 2006;26(6):565\u2013574.","journal-title":"Medical decision making."},{"issue":"21","key":"9341_CR29","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","volume":"34","author":"KF Kerr","year":"2016","unstructured":"Kerr KF, Brown MD, Zhu K, Janes H. Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. Journal of clinical oncology. 2016;34(21):2534\u20132540.","journal-title":"Journal of clinical oncology."},{"issue":"2","key":"9341_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1245\/s10434-018-6929-0","volume":"26","author":"X Tang","year":"2019","unstructured":"Tang X, Zhou X, Li Y, et al. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study. Annals of surgical oncology. 2019;26(2):321\u2013328.","journal-title":"Annals of surgical oncology."},{"issue":"29","key":"9341_CR31","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.2217\/fon-2019-0007","volume":"15","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pang Z, Chen X, et al. Survival nomogram for patients with initially diagnosed metastatic non-small-cell lung cancer: a SEER-based study. Future oncology. 2019;15(29):3395\u20133409.","journal-title":"Future oncology."},{"issue":"6","key":"9341_CR32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ijerph16060908","volume":"16","author":"TA Yuan","year":"2019","unstructured":"Yuan TA, Lu Y, Edwards K, Jakowatz J, Meyskens FL, Liu-Smith F. Race-, Age-, and Anatomic Site-Specific Gender Differences in Cutaneous Melanoma Suggest Differential Mechanisms of Early- and Late-Onset Melanoma. Int J Environ Res Public Health. 2019;16(6):908.","journal-title":"Int J Environ Res Public Health."},{"issue":"6","key":"9341_CR33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CJI.0000000000000264","volume":"42","author":"W Haque","year":"2019","unstructured":"Haque W, Verma V, Butler EB, Teh BS. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States. Journal of immunotherapy. 2019;42(6):228\u2013235.","journal-title":"Journal of immunotherapy."},{"issue":"7","key":"9341_CR34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/cancers12071819","volume":"12","author":"M Bellenghi","year":"2020","unstructured":"Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Car\u00e8 A. Sex and Gender Disparities in Melanoma. Cancers (Basel). 2020;12(7):1819.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"9341_CR35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2020.03.094","volume":"83","author":"R Tripathi","year":"2020","unstructured":"Tripathi R, Archibald LK, Mazmudar RS, et al. Racial differences in time to treatment for melanoma. Journal of the American Academy of Dermatology. 2020;83(3):854\u2013859.","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"8","key":"9341_CR36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jamaophthalmol.2020.2254","volume":"138","author":"N Rajeshuni","year":"2020","unstructured":"Rajeshuni N, Zubair T, Ludwig CA, Moshfeghi DM, Mruthyunjaya P. Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014. JAMA ophthalmology. 2020;138(8):876\u2013884.","journal-title":"JAMA ophthalmology."},{"issue":"6","key":"9341_CR37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/09546634.2019.1657223","volume":"31","author":"O Abdel-Rahman","year":"2020","unstructured":"Abdel-Rahman O. Prognostic impact of socioeconomic status among patients with malignant melanoma of the skin: a population-based study. The Journal of dermatological treatment. 2020;31(6):571\u2013575.","journal-title":"The Journal of dermatological treatment."},{"key":"9341_CR38","doi-asserted-by":"crossref","unstructured":"Maas JA, Monreal AJ, Diaz EL, Castro G, Rodriguez de la Vega P, Varella M. Marital Status and Survival in Patients Diagnosed with Melanoma. Dermatology research and practice. 2020;2020:2485401.","DOI":"10.1155\/2020\/2485401"},{"key":"9341_CR39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2147\/OPTH.S238034","volume":"14","author":"A Loya","year":"2020","unstructured":"Loya A, Ayaz T, Weng CY. Impact of Marital Status on Survival in Patients with Ocular and Periocular Malignancies: A Retrospective Analysis of 3159 Patients from the SEER Database. Clinical ophthalmology. 2020;14:1127\u20131133.","journal-title":"Clinical ophthalmology."},{"issue":"9","key":"9341_CR40","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1245\/s10434-020-08657-6","volume":"27","author":"DJW Rauwerdink","year":"2020","unstructured":"Rauwerdink DJW, Molina G, Frederick DT, et al. Mixed Response to Immunotherapy in Patients with Metastatic Melanoma. Annals of surgical oncology. 2020;27(9):3488\u20133497.","journal-title":"Annals of surgical oncology."},{"issue":"1","key":"9341_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/mmt-2016-0018","volume":"4","author":"R Tyrell","year":"2017","unstructured":"Tyrell R, Antia C, Stanley S, Deutsch GB. Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy. Melanoma management. 2017;4(1):61\u201368.","journal-title":"Melanoma management."},{"key":"9341_CR42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jss.2017.02.070","volume":"214","author":"J Kurtz","year":"2017","unstructured":"Kurtz J, Beasley GM, Agnese D, et al. Surveillance strategies in the follow-up of melanoma patients: too much or not enough? The Journal of surgical research. 2017;214:32\u201337.","journal-title":"The Journal of surgical research."},{"issue":"4","key":"9341_CR43","first-page":"908","volume":"81","author":"MLH Baranowski","year":"2019","unstructured":"Baranowski MLH, Yeung H, Chen SC, Gillespie TW, Goodman M. Factors associated with time to surgery in melanoma: an analysis of the National Cancer Database. The British journal of dermatology. 2019;81(4):908\u2013916.","journal-title":"The British journal of dermatology."},{"issue":"24","key":"9341_CR44","doi-asserted-by":"crossref","first-page":"e16059","DOI":"10.1097\/MD.0000000000016059","volume":"98","author":"J Yang","year":"2019","unstructured":"Yang J, Pan Z, Zhao F, et al. A nomogram for predicting survival in patients with nodular melanoma: a population-based study. Medicine. 2019;98(24):e16059.","journal-title":"Medicine."},{"issue":"3","key":"9341_CR45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/bjs.10995","volume":"106","author":"D Verver","year":"2019","unstructured":"Verver D, van Klaveren D, Franke V, et al. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes. The British journal of surgery. 2019;106(3):217\u2013225.","journal-title":"The British journal of surgery."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09341-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:20:00Z","timestamp":1623072000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09341-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["9341"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09341-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,15]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wei Li, Yang Xiao, Xuewen Xu, and Yange Zhang have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}